Skip to main content
Premium Trial:

Request an Annual Quote

Genicon Sciences and Qiagen to co-Distribute RLS-based Microarray Tools

NEW YORK, Feb. 5 - Genicon Sciences of San Diego and Qiagen announced yesterday an amendment to their distribution and supply agreement as Genicon launched an RLS two-color nucleic acid microarray toolkit.


The two companies will now have co-exclusive distribution rights in North America for microarray toolkits based on Genicon's resonance light scattering technology. Qiagen products will be sold under the HiLight brand name.


Genicon, meantime, introduced its two-color nucleic acid microarray toolkit, which is part of the RLS array detection system for gene expression analysis. The product is designed to derive more data from smaller amounts of biological material, based on the RLS system, which uses a non-fluorescent signal generation and detection technology based on nanometer sized metal colloidal particles.


Click here for more information.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.